Baker McKenzie Advises Olink Holding AB (publ) in $3.1 Billion Sale

Baker McKenzie advised Olink Holding AB (publ), a leader in next generation proteomics in its sale to Thermo Fisher Scientific (NYSE: TMO) in an all-cash transaction valued at approximately $3.1 billion (including net cash).

Co-led by partners Mark Mandel and Henric Roth together with Piotr Korzynski and Carl Svernlöv, the Baker McKenzie team includes:

• M&A/Capital Markets: Mark Mandel, Piotr Korzynski, Justin Bryant, Roger Bivans, Gwen Karanadze, Adam Buehler, Sarah Rodrigue, Lewis Assness, Shelly Kuo, Adeola Alade, Zach Bassen, Rachel Gray, Franchesca Alamo
• Stockholm M&A/Capital Markets: Henric Roth, Carl Svernlöv, Per Blom, Monica Ericson
• Antitrust: John Fedele, Heidi Smucker
• Benefits: Thomas Asmar, Sesen Hailemichael
• Foreign Investment: Rod Hunter, Alexandra Kumar
• Employment: Elizabeth Ebersole, Adeola Olowude, Amanda Cohen
• Stockholm Employment: Ida Cederborg and Amanda Thieme
• Environment: Jessica Wicha
• Intellectual Property: Adam Aft, Robby Turner
• International Commercial: Sylwia Lis, Lise Test,
• Real Estate: Sarah Winston, Sarah Swain, Amanda Jaramillo
• Tax: Kai Kramer, Ross Staine, Joseph Chung
• Stockholm Tax: Linnea Back, Ulrika Udén, Oskar Salenstedt
• Litigation: Peter Tomczak, Matthew Allison, Geoff Martin, Xin Tao